Debenhams shoppers are also loving the make-up staple which is currently reduced by 20% for a limited time. For money-saving ...

April 11 is the last day to submit an eligibility claim for a one-time food assistance of $177 per child under the School Year 2024 summer electronic benefit transfer, EBT, according to the ...

Astronomers, led by Cambridge University, believe they have found signs of biological activity on exoplanet K2-18b, which is ...

Tough cuts to Personal Independence Payments (PIP) will make it harder for new claimants to qualify and existing claimants to keep all of their benefits. From next year, applicants will need to ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Who benefits when markets lurch? Generally, those sitting on giant piles of cash. Investors who find ...

HE bravely admitted hitting rock bottom after splashing all his TV earnings on booze, drugs and partying - but Jack Fincham has vowed to finally get on the straight and narrow. The Love Island ...

Malaysia, India and the Philippines will likely benefit from trade diversion owing to US’ reciprocal tariffs as they have been levied with lower tariffs than other economies such as China ...

President Trump's administration wants a weaker dollar and that's bullish for bitcoin (BTC), asset manager Bitwise said in a report Tuesday. "When it comes to the tariff push, the thing i'm most ...

We’re also rebalancing Universal Credit payment levels, so the benefit’s main rate rises permanently above inflation for the first time, in a boost for low-income families.” ...

NATO panel at the 40th Space Symposium, from left to right, Tom Goffus, NATO assistant secretary for general operations, Royal Air Force Air Marshall John Stringer, Maj. Gen. Philippe Adam, French ...

LITTLE ROCK, Ark. (KAIT/KARK) – An Arkansas bill aims to prevent pharmacy benefit managers from owning pharmacies. According to content partner KARK, this would prevent PBMs like CVS Health from ...

New topline data from the MINT trial (NCT04524273), which is investigating inebilizumab in patients with generalized myasthenia gravis who are acetylcholine receptor (AChR) antibody or muscle ...